Cargando…

Serum metabolomic profiling reveals potential biomarkers in assessing the management of women with polycystic ovary syndrome: a randomized controlled trial

BACKGROUND: As one of the most common endocrinal disorders for women at childbearing age, the diagnostic criteria of polycystic ovary syndrome (PCOS) have been defined differently among different international health organizations. Phenotypic heterogeneity of PCOS also brings about difficulties for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Xuesong, Deng, Yan, Wang, Yanfang, Xue, Wei, Zhu, Shiyang, Ma, Xiao, Ma, Ruilin, Sun, Aijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850823/ https://www.ncbi.nlm.nih.gov/pubmed/34873082 http://dx.doi.org/10.1097/CM9.0000000000001705

Ejemplares similares

The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Ma, Ruilin, et al.
Publicado: (2021)

Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China
por: Ma, Ruilin, et al.
Publicado: (2021)

Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
por: Yu, Ying, et al.
Publicado: (2021)

Combined Transcriptomic and Metabolomic Analysis of Women with Polycystic Ovary Syndrome
por: Tian-Min, Ye, et al.
Publicado: (2022)

Metabolomic study combined with the low-level light therapy of Chinese acupuncture points and combined oral contraceptives in treatment of primary dysmenorrhea: A prospective, multicenter, randomized controlled study
por: Wang, Hanbi, et al.
Publicado: (2023)

Comparative evaluation of low-level light therapy and ethinyl estradiol and desogestrel combined oral contraceptive for clinical efficacy and regulation of serum biochemical parameters in primary dysmenorrhoea: a prospective randomised multicentre trial
por: Zhu, Shiyang, et al.
Publicado: (2022)

Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS)
por: Escobar-Morreale, Héctor F., et al.
Publicado: (2023)

Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey
por: Yan, Deng, et al.
Publicado: (2021)

The Disparity in the Management of Polycystic Ovary Syndrome between Obstetrician-Gynecologists in Different-Level Hospitals under the Hierarchical Medical System
por: Wang, Yue, et al.
Publicado: (2022)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
por: Hu, Cong, et al.
Publicado: (2020)

Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023)

Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome
por: Tian, Ye, et al.
Publicado: (2023)

Metabolomic Insight into Polycystic Ovary Syndrome—An Overview
por: Rajska, Anna, et al.
Publicado: (2020)

Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis
por: Zhao, Yue, et al.
Publicado: (2012)

Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome
por: Yang, Zhandong, et al.
Publicado: (2022)

Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study
por: Ding, Ying, et al.
Publicado: (2022)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021)

Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
por: Vinaixa, Maria, et al.
Publicado: (2011)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

The mitochondrial profile in women with polycystic ovary syndrome: impact of exercise
por: Malamouli, Melpomeni, et al.
Publicado: (2022)

Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients
por: Li, Li, et al.
Publicado: (2016)

Effect of Low-Power Visible-Light-Activated Photodynamic Therapy (PDT) on Primary Dysmenorrhea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Gu, Bei, et al.
Publicado: (2022)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome
por: Stokkeland, Live Marie T, et al.
Publicado: (2021)

The Associations between Sex Hormones and Lipid Profiles in Serum of Women with Different Phenotypes of Polycystic Ovary Syndrome
por: Bizoń, Anna, et al.
Publicado: (2021)

UPLC/Q-TOF-MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome
por: Fan, Xuemei, et al.
Publicado: (2019)

Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome
por: Guo, Zaixin, et al.
Publicado: (2023)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
por: Couto Alves, A, et al.
Publicado: (2017)

Circular RNA expression profiling of granulosa cells in women of reproductive age with polycystic ovary syndrome
por: Zhang, Chunren, et al.
Publicado: (2019)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Serum Vitamin D Levels in Fertile and Infertile Women with Polycystic Ovary Syndrome
por: Kokanalı, Demet, et al.
Publicado: (2019)

Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
por: Hamilton, Kristen P, et al.
Publicado: (2019)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
por: Diboun, Ilhame, et al.
Publicado: (2021)

Identification of Potential Biomarkers for Urine Metabolomics of Polycystic Ovary Syndrome Based on Gas Chromatography-Mass Spectrometry
por: Zou, Ying, et al.
Publicado: (2018)

Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
por: Li, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f2aedpijsbgkvbb9var5mm1dr7